BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22840246)

  • 1. What will allergen immunotherapy look like in the future?
    Nelson HS
    Ann Allergy Asthma Immunol; 2012 Aug; 109(2):87-9. PubMed ID: 22840246
    [No Abstract]   [Full Text] [Related]  

  • 2. What should drive the choice of allergen for immunotherapy in polysensitized patients?
    Ciprandi G; Incorvaia C; Puccinelli P; Dell'Albani I; Frati F
    Ann Allergy Asthma Immunol; 2012 Aug; 109(2):148-9. PubMed ID: 22840259
    [No Abstract]   [Full Text] [Related]  

  • 3. Some highlights of the first century of immunotherapy.
    Nelson HS
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):417-21. PubMed ID: 22018612
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergen immunotherapy: a history of the first 100 years.
    Fitzhugh DJ; Lockey RF
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):554-9. PubMed ID: 21971334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological mechanisms in allergen-specific immunotherapy: impact on future trends in type-1 allergy management].
    Ebner C
    Wien Med Wochenschr; 1999; 149(14-15):438-41. PubMed ID: 10584289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy.
    Bauer CS; Rank MA
    J Allergy Clin Immunol; 2014 Sep; 134(3):765-765.e2. PubMed ID: 25171871
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist.
    Bernstein DI; Blaiss MS; Cox LS; Finegold I; Lanier BQ; Nelson HS; Wallace DV
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):422-5. PubMed ID: 22018613
    [No Abstract]   [Full Text] [Related]  

  • 10. The current state of recombinant allergens for immunotherapy.
    Pauli G; Malling HJ
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immunotherapy, one century later.
    Passalacqua G; Bush RK
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):551-3. PubMed ID: 21971328
    [No Abstract]   [Full Text] [Related]  

  • 13. Pollen and inhalant allergy.
    Fountain DW
    Biologist (London); 2002 Feb; 49(1):5-9. PubMed ID: 11852278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerized allergens.
    Patterson R; Suszko IM
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):241-6. PubMed ID: 6354090
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of respiratory allergy with allergy immunotherapy tablets.
    Bachert C
    Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rush allergen subcutaneous immunotherapy administered with infusion pump.
    Sastre J; Vallejo L; Hernández E; Fernández-Nieto M; Nieto PR
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):459-60. PubMed ID: 22018619
    [No Abstract]   [Full Text] [Related]  

  • 18. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apropos of sublingual specific immunotherapy].
    Sabbah A
    Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of molecular biology on allergen immunotherapy.
    Bush RK
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):557-8. PubMed ID: 21030836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.